DOI: http://dx.doi.org/10.18203/2349-2902.isj20215153

Curative treatment of pancreatic functioning insulinoma with stereotactic ablative radiation therapy: case report

Aws Abdulrahman Alsuhaibani, Abdullah Abdulrahman Alsuhaibani, Tareq Salah Hassan

Abstract


Insulinoma is the most common pancreatic neuroendocrine tumor (NET). It is a rare disease account for 1-2% of pancreatic tumors and affect approximately up to 3 patients per million per year. complete surgical resection or debulking are standard of care option. However, surgery is associated with short and long-term post-operative morbidity and may not be appropriate for all patients. In This case we present management and cure of a case of functioning insulinoma with stereotactic ablative radiosurgery in an unfit patient for surgery.


Keywords


Insulinoma, Stereotactic radiation, SBRT, SABR, Radiation

Full Text:

PDF

References


De Herder WW, Niederle B, Scoazec J-Y. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology. 2006;84(3):183-8.

Okabayashi T, Shima Y, Sumiyoshi T. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829.

Bouslama K, Maghrebi H, Bedioui H, Bouslama KJJAHG. Pancreatic insulinoma: diagnostic approach and therapeutic modalities. BMC Res Notes. 2014;8:11-5.

Giannis D, Moris D, Karachaliou G-S. Insulinomas: from diagnosis to treatment. A review of the literature. J BUON. 2020;25(3):1302-14.

Metz DC, Jensen RTJG. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135(5):1469-92.

Myrehaug S, Hallet J, Chu W. Proof of concept for stereotactic body radiation therapy in the treatment of functional neuroendocrine neoplasms. J Radiosurg SBRT. 2020;6(4):321.

De Herder WW, van Schaik E, Kwekkeboom D, Feelders RAJCe. New therapeutic options for metastatic malignant insulinomas. Mov Disord. 2011;75(3):277-84.

Zhao Yp, Zhan Hx, Zhang Tp. Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol. 2011;103(2):169-74.

Baudin E, Caron P, Lombard-Bohas C. Malignant insulinoma: recommendations for characterisation and treatment. Ann Endocrinol (Paris). 2013;74(5-6):523-33.

Whipple AO, Frantz VKJAos. Adenoma of islet cells with hyperinsulinism: a review. Ann Surg. 1935;101(6):1299.

Nikfarjam M, Warshaw AL, Axelrod L. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008;247(1):165.

Grant CSJBp, gastroenterology rC. Insulinoma. 2005;19(5):783-98.

Chan DL, Dixon M, Law CH. Outcomes of cytoreductive surgery for metastatic low-grade neuroendocrine tumors in the setting of extrahepatic metastases. Ann Surg Oncol. 2018;25(6):1768-74.

De Baere T, Deschamps F, Tselikas L. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur J Endocrinol. 2015;172(4):R151-66.

Berelavichus SV, Kriger AG, Dugarova RS, Kaldarov ARJSCCM. Treatment of Insulinomas with Minimally Invasive Physical Procedure. Literature Review. 2019;1(2):104-12.

Ahmed KA, Caudell JJ, El-Haddad G. Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2016;95(5):1399-404.

Ghaly M, Gogineni E, Saif MWJP. The Evolving Field of Stereotactic Body Radiation Therapy in Pancreatic Cancer. Pancreas (Fairfax). 2019;3(1):9.

Leksell LJAcs. The stereotactic method and radiosurgery of the brain. Acta Chir Scand. 1951;102:316-9.

Blomgren H, Lax I, Näslund I, Svanström RJAo. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients. Acta Oncol. 1995;34(6):861-70.

Videtic GM, Chang JY, Chetty IJ. ACR Appropriateness Criteria® Early-Stage Non-Small-Cell Lung Cancer. Am J Clin Oncol. 2014;37(2):201-7.

Kollar L, Rengan R. Stereotactic body radiotherapy. Paper presented at: Seminars in oncology. 2014.

Pollom EL, Alagappan M, Von Eyben R. Single-versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. Int J Radiat Oncol Biol Phys. 2014;90(4):918-25.

Koong AC, Le QT, Ho A. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004;58(4):1017-21.

Goodman KA, Koong AC. 26 Cyber Knife Radiosurgery for Pancreatic Cancer. 2005.

Huscher CGS, Mingoli A, Sgarzini G, Mereu A, Gasperi MJSi. Image-guided robotic radiosurgery (Cyber Knife) for pancreatic insulinoma: is laparoscopy becoming old? Surg Innov. 2012;19(1):NP14-7.